The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema

Background/Aims. To assess the effect of intravitreal bevacizumab injection (IVBI) for the treatment of macular edema due to infectious and noninfectious uveitides. Design. Retrospective interventional case series. Methods. A chart review was performed on all the patients who were diagnosed with uve...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hassan Al-Dhibi, Issam H. Hamade, Ali Al-Halafi, Maan Barry, Charbel Bou Chacra, Vishali Gupta, Khalid F. Tabbara
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2014/729465
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fellow Eye Macular Edema Improvement after Intravitreal Bevacizumab for Radiation Retinopathy
by: Isis A. S. Brito, et al.
Published: (2015-01-01)

OCT Biomarkers in Diagnostic of Uveitic and Radiation-induced Macular Edema
by: I. E. Panova, et al.
Published: (2025-06-01)

Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema
by: Jovanović Sandra, et al.
Published: (2015-01-01)

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Jia-Kang Wang, et al.
Published: (2016-01-01)

The effect of intravitreal administration of bevacizumab on macular edema and visual acuity in age-related macular degeneration with subfoveolar choroidal neovascularisation
by: Ristić Dragana, et al.
Published: (2013-01-01)

Revisiting the Role of Intravitreal Triamcinolone in Diabetic Macular Edema: 12-Month Outcomes after Bevacizumab Failure
by: Sukhum Silpa-archa, et al.
Published: (2025-06-01)

Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Takafumi Hirashima, et al.
Published: (2014-01-01)

Risk factors and Response of Branch Retinal Vein Occlusion induced Macular Edema to intravitreal injections of Triamcinolone and Bevacizumab
by: Singhai Prakhar, et al.
Published: (2017-07-01)

Interferon alpha-2b addition to intravitreal bevacizumab for diabetic macular edema: a randomized controlled trial
by: Saeed Karimi, et al.
Published: (2025-04-01)

Effectiveness of aflibercept in treating bevacizumab resistant macular edema
by: Hussain Khudair Yassin
Published: (2024-12-01)

Intravitreal Corticosteroids in the Management of Refractory Macular Edema in Birdshot Chorioretinopathy
by: Alves Ambrósio J, et al.
Published: (2025-03-01)

Simultaneous Presentation of Uveitic Disc Edema and Papilledema in an Adult
by: Chase A. Liaboe, et al.
Published: (2020-01-01)

Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry
by: Jurgen Sota, et al.
Published: (2025-07-01)

Intravitreal Ranibizumab versus Razumab in treatment naïve diabetic macular edema
by: Dhandapani A, et al.
Published: (2025-06-01)

Full Thickness Macular Hole Following Intravitreal Bevacizumab for A Vascularised Pigment Epithelial Detachment
by: Neha Goel
Published: (2021-04-01)

Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis
by: Cassandra C. Lautredou, et al.
Published: (2018-01-01)

Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes
by: Hüseyin Baran Özdemir, et al.
Published: (2019-12-01)

The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines
by: A. Zh. Fursova, et al.
Published: (2023-03-01)

Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema
by: Vinodh Kakkassery, et al.
Published: (2017-01-01)

Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
by: Eric K. Newcott, et al.
Published: (2015-01-01)

Short-term real-world outcomes of diabetic macular edema treated with intravitreal faricimab.
by: Toshiaki Hirakata, et al.
Published: (2025-01-01)

Intravitreal and Subtenon Depot Triamcinolone as Treatment of Retinitis Pigmentosa Associated Cystoid Macular Edema
by: Sidnei Barge, et al.
Published: (2013-01-01)

Patient Preferences with Regard to Laser versus Intravitreal Injections in the Treatment of Diabetic Macular Edema
by: Lauren Mason, et al.
Published: (2017-01-01)

Corrigendum: Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
by: Gaixia Zhai, et al.
Published: (2025-05-01)

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
by: Beuy Joob, et al.
Published: (2017-03-01)

Time-in-Range Analysis of Responses after Intravitreal Dexamethasone Therapy in Eyes with Diabetic Macular Edema
by: Igor Kozak, MD, PhD, et al.
Published: (2025-09-01)

Comparison of three loading doses of bevacizumab and ranibizumab for macular edema due to branch retinal vein occlusion
by: Sibel Coşkun Akdemir, et al.
Published: (2025-05-01)

Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery
by: Yo-Chen Chang, et al.
Published: (2018-01-01)

Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
by: Claudio Furino, et al.
Published: (2017-01-01)

Combined Treatment of Post-Thrombotic Macular Edema with Navigation Laser Coagulation and Intravitreal Administration of Angiogenesis Inhibitors
by: I. A. Krylova, et al.
Published: (2023-04-01)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain.
by: Shumpei Obata, et al.
Published: (2021-01-01)

Evaluation of the Effect of Repeated Intravitreal Bevacizumab Injections on the Macular Microvasculature of a Diabetic Patient Using Optical Coherence Tomography Angiography
by: Ayman G. Elnahry, et al.
Published: (2019-01-01)

The Clinical Spectrum and Outcomes of Ocular Syphilis in Saudi Arabia: The Emergence of a Uveitic Masquerader
by: Abrar A. Alhawsawi, et al.
Published: (2025-02-01)

Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema
by: Yao Shen, et al.
Published: (2025-08-01)

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
by: Patricia Udaondo, et al.
Published: (2011-01-01)

Effect of multiple intravitreal injections of conbercept on the cornea in patients with branch retinal vein occlusion-induced macular edema
by: Gaixia Zhai, et al.
Published: (2025-06-01)

Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema
by: Yoshinari Saima, et al.
Published: (2024-06-01)

The psychological status of patients with delayed intravitreal injection for treatment of diabetic macular edema due to the COVID-19 pandemic.
by: Mohamad Azlan Zaini, et al.
Published: (2023-01-01)

Preferences of Hospital Pharmacists for the Different Attributes of Intravitreal Treatments for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Spain: The SEEKING Study
by: José Luis Poveda, et al.
Published: (2025-05-01)

The Short-Term Effect of Intravitreal Bevacizumab Injection on Intraocular Pressure
by: Şehnaz Özçalışkan, et al.
Published: (2014-10-01)